Literature DB >> 31341013

Delaying and withholding interventions: ethics and the stepped wedge trial.

Ariella Binik1,2.   

Abstract

Ethics has been identified as a central reason for choosing the stepped wedge trial over other kinds of trial designs. The potential advantage of the stepped wedge design is that it provides all arms of the trial with the active intervention over the course of the study. Some groups receive it later than others, but the study intervention is not withheld from any group. This feature of the stepped wedge design seems particularly ethically advantageous in two instances: (1) when the study intervention appears especially likely to be effective and (2) when the consequences of not receiving the intervention may be dire. But despite an increase in the use of the stepped wedge design and appeals to its ethical superiority as the motivation for its selection, there has been limited attention to the stepped wedge trial in the ethics literature. In the following, I examine whether there are persuasive ethical reasons to prefer or to require a stepped wedge trial. I argue that while the stepped wedge design is ethically permissible, it is not morally superior to other kinds of trials. To this end, I examine the ethical justification for providing, withholding, and delaying interventions in research. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords:  clinical trials; ethics; research ethics

Year:  2019        PMID: 31341013     DOI: 10.1136/medethics-2018-105138

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials.

Authors:  Carole A Federico; Patrick J Heagerty; John Lantos; Pearl O'Rourke; Vasiliki Rahimzadeh; Jeremy Sugarman; Kevin Weinfurt; David Wendler; Benjamin S Wilfond; David Magnus
Journal:  Contemp Clin Trials       Date:  2022-02-15       Impact factor: 2.261

2.  Ottawa Statement does not impede randomised evaluation of government health programmes.

Authors:  Charles Weijer; Monica Taljaard
Journal:  J Med Ethics       Date:  2019-11-26       Impact factor: 2.903

3.  A Society of General Internal Medicine Position Statement on the Internists' Role in Social Determinants of Health.

Authors:  Elena Byhoff; Shreya Kangovi; Seth A Berkowitz; Matthew DeCamp; Elizabeth Dzeng; Mark Earnest; Cristina M Gonzalez; Sarah Hartigan; Reena Karani; Milad Memari; Brita Roy; Mark D Schwartz; Anna Volerman; Karen DeSalvo
Journal:  J Gen Intern Med       Date:  2020-06-09       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.